10.30.06: Biotechnology Report
   
A roundtable forum, 2 analysts and top management from 19 sector firms examine the biotechnology sector in this 86 page report from The Wall Street Transcript.

  1. Roundtable Forum: Kevin DeGeeter, H.C. Wainwright & Co.; Jason Kantor, RBC Capital Markets; Howard Liang, Leerink Swann & Company, Inc.

  2. Small Cap Oncology Companies: Aaron Reames, A.G. Edwards & Sons

  3. Micro-Cap Biotechnology Companies: Rahul Jasuja, MDB Capital Group LLC

  4. Off the Record: Off the Record asks company leadership which management teams in their sector they most respect for their ability to execute and generate shareholder value.

  5. CEO Interviews (average 2,500 words): Top management from 19 sector firms examine the outlook for their firm and sector. Firms interviewed include: Arena Pharmaceuticals, Bioanalytical Systems, CEL-SCI Corporation, Cepheid, Diversa Corporation, Dynavax Technologies Corp., GenVec, ImmuCell Corporation, inVentiv Health, Kosan Biosciences, Medarex, Inc., Medivation, Neurologix, Opexa Therapeutics, Oragenics, QuantRx Biomedical, Stem Cell Innovations and Unigene Laboratories.

    Topics covered: Increase in M&A activity - Market cap rotation - Commercial focus in biotech - Oncology space - Backdating issues - FDA regulatory process - Immunomodulatory drugs - Cancer treatments - Emerging technologies 

    Companies covered: Millennium (MLNM), ZymoGenetics (ZGEN), AEterna Zentaris (AEZS), Antares Pharma (AIS), Vertex (VRTX), Onyx Pharmaceuticals (ONXX), Celgene (CELG), Alexza Pharmaceuticals (ALXA), Bioenvision (BIVN), GTx (GTXI), AstraZeneca (AZN), Genzyme (GENZ), Serono (SRA), Biogen Idec (BIIB), Palatin (PTN), Maxygen (MAXY), Allos Therapeutics (ALTH), Pfizer (PFE), Dendreon (DNDN) and Emisphere (EMIS).
    ORDER THIS REPORT NOW! ONLY $175
    The report will be mailed first class. For fedex delivery, specify in the report details section and either include your fedex number or we will add $15 delivery charge. All sales are final.  Questions, call (212) 952-7433, or email us

    For immediate access online - click here to gain a password.  

    Report details:  
    Your Name:  
    		 Company: 
    Address: 
    		 City: 
    State/Province:
    		 ZIP/Postal Code:
           		 Country:
    Phone:
    		 E-Mail:

    BILLING INFORMATION
    Credit Card
    		 Expiration Month/Year:
    Credit Card Number: 

     This Issue costs $175 - and is non-returnable.   

    The Wall Street Transcript does not endorse the views of any interviewee nor does it make stock recommendations.

 

Investors and Industry Execs.

The Wall Street Transcript has been used by investors and industry executives for 40 years as a unique tool for company and industry research.

TWST's roundtable panels and analyst interviews provide a sector perspective from Wall Street's best. 

Money manager interviews provide the view from the buy-side.

CEO interviews with hundreds of companies from the major sectors gives the company perspective right from the top.


Subscribe to a unique research tool for investors and industry executives. Call (212) 952 7433 or click here.

Sincerely,

Andrew Pickup
Publisher
HOME PRODUCTS SUBSCRIBE ABOUT ARCHIVE HOTLINE CONTACT EUROPE